Literature DB >> 24676471

LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (review).

Xi Wang1, Chao He1, Xiaotong Hu1.   

Abstract

LIM homeobox genes are one of the most important subfamilies of homeobox genes which encode LIM-homeodomain (LIM-HD) proteins featuring two LIM domains in their amino termini and a centrally located HD that is used to interact with specific DNA elements in target genes. Numerous studies have reported their fundamental roles in the development of various organisms; however, little is known about their functions in cancer. Recently, research has shown that LIM homeobox genes also play an important role in cancer development. Among 12 human LIM homeobox genes, 10 LIM-HD proteins have been reported to be associated with cancer. In the present review, we mainly summarize the functions of these genes in various types of cancer and their potential as biomarkers and the related challenges. More in-depth research concerning LIM homeobox genes in cancer from a signaling pathway perspective may help to understand tumor profiles, establish biomarkers and guide choices for combinatorial drug therapies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676471     DOI: 10.3892/or.2014.3112

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

1.  Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.

Authors:  Terri L Messier; Joseph R Boyd; Jonathan A R Gordon; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  J Cell Physiol       Date:  2016-03-10       Impact factor: 6.384

2.  LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.

Authors:  Nicola Mosca; Fatma Zohra Khoubai; Sandrine Fedou; Juan Carrillo-Reixach; Stefano Caruso; Alvaro Del Rio-Alvarez; Emeric Dubois; Christophe Avignon; Nathalie Dugot-Senant; Catherine Guettier; Charlotte Mussini; Jessica Zucman-Rossi; Carolina Armengol; Pierre Thiébaud; Philippe Veschambre; Christophe François Grosset
Journal:  Liver Cancer       Date:  2021-12-21       Impact factor: 12.430

3.  Hsa_circ_0008726 regulates the proliferation, migration, and invasion of trophoblast cells in preeclampsia through modulating the miR-1290-LHX6 signaling pathway.

Authors:  Yongyan Zhang; Shuai Fang; Jiayi Wang; Siqian Chen; Rongrong Xuan
Journal:  J Clin Lab Anal       Date:  2022-06-13       Impact factor: 3.124

4.  Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma.

Authors:  Cayla Boycott; Megan Beetch; Tony Yang; Katarzyna Lubecka; Yuexi Ma; Jiaxi Zhang; Lucinda Kurzava Kendall; Melissa Ullmer; Benjamin S Ramsey; Sandra Torregrosa-Allen; Bennett D Elzey; Abigail Cox; Nadia Atallah Lanman; Alisa Hui; Nathaniel Villanueva; Aline de Conti; Tao Huan; Igor Pogribny; Barbara Stefanska
Journal:  Epigenetics       Date:  2022-05-03       Impact factor: 4.861

5.  ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

Authors:  Lin Qi; Zhong-Yong Wang; Xin-Rong Shao; Miao Li; Shu-Na Chen; Xue-Qi Liu; Shi Yan; Bo Zhang; Xu-Dong Zhang; Xin Li; Wenxue Zhao; Ji-An Pan; Bo Zhao; Xing-Ding Zhang
Journal:  Oncogene       Date:  2020-08-04       Impact factor: 9.867

6.  Phosphorylation of islet-1 serine 269 by CDK1 increases its transcriptional activity and promotes cell proliferation in gastric cancer.

Authors:  Qiong Shi; Xiaomei Ni; Ming Lei; Quansong Xia; Yan Dong; Qiao Zhang; Weiping Wang
Journal:  Mol Med       Date:  2021-05-07       Impact factor: 6.354

Review 7.  Homeodomain proteins: an update.

Authors:  Thomas R Bürglin; Markus Affolter
Journal:  Chromosoma       Date:  2015-10-13       Impact factor: 4.316

8.  ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis.

Authors:  Lin Li; Fuwen Sun; Xiaoyan Chen; Minghui Zhang
Journal:  Onco Targets Ther       Date:  2018-02-14       Impact factor: 4.147

9.  Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.

Authors:  Jinrong Liao; Jinghui Lin; Dong Lin; Changyan Zou; Jessica Kurata; Renjang Lin; Zhiyong He; Ying Su
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

10.  ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.

Authors:  Qiong Shi; Weiping Wang; Zhuqing Jia; Ping Chen; Kangtao Ma; Chunyan Zhou
Journal:  Oncotarget       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.